Equities Research Analysts’ Upgrades for January 20th (BMRN, CURB, CVX, EAT, PEG, PGNY, STRO, SU, TT, UDR)

Equities Research Analysts’ upgrades for Tuesday, January 20th:

BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded by analysts at Canaccord Genuity Group Inc. from a hold rating to a buy rating. They currently have $98.00 price target on the stock, up from their previous price target of $84.00.

Curbline Properties (NYSE:CURB) was upgraded by analysts at Truist Financial Corporation from a hold rating to a buy rating.

Chevron (NYSE:CVX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $176.00 target price on the stock.

Brinker International (NYSE:EAT) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. They currently have $200.00 target price on the stock, up from their previous target price of $160.00.

Public Service Enterprise Group (NYSE:PEG) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. The firm currently has $92.00 price target on the stock, up from their previous price target of $88.00.

Progyny (NASDAQ:PGNY) was upgraded by analysts at Citizens Jmp from a market perform rating to an outperform rating. The firm currently has $30.00 price target on the stock.

Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citizens Jmp from a market perform rating to a market outperform rating. They currently have $23.00 target price on the stock.

Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Trane Technologies (NYSE:TT) was upgraded by analysts at Oppenheimer Holdings, Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings, Inc. currently has $460.00 price target on the stock.

United Dominion Realty Trust (NYSE:UDR) was upgraded by analysts at Truist Financial Corporation from a hold rating to a buy rating. The firm currently has $42.00 price target on the stock, up from their previous price target of $41.00.

Wingstop (NASDAQ:WING) was upgraded by analysts at Melius from a hold rating to a buy rating. They currently have $350.00 price target on the stock.